Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/13116
Full metadata record
DC FieldValueLanguage
dc.contributor.authorMacGregor, Duncanen
dc.contributor.authorMurone, Carmelen
dc.contributor.authorSong, Ken
dc.contributor.authorAllen, A Men
dc.contributor.authorPaxinos, Gen
dc.contributor.authorMendelsohn, Frederick AOen
dc.date.accessioned2015-05-16T02:54:01Z
dc.date.available2015-05-16T02:54:01Z
dc.date.issued1995-03-27en
dc.identifier.citationBrain Research; 675(1-2): 231-40en
dc.identifier.govdoc7796134en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/13116en
dc.description.abstractThe distribution of the AT1 and AT2 subtypes of angiotensin II receptor was mapped in the adult human central nervous system using quantitative in vitro autoradiography. Binding in all forebrain, midbrain, pontine, medullary and spinal cord sites where angiotensin II receptors have previously been described is of the AT1 subtype, as is binding in the small and large arteries in the adjacent meninges and in choroid plexus. By contrast, both AT1 and AT2 receptors occur in the molecular layer of the cerebellum. Angiotensin II AT1 receptors in the brain show a moderate degree of conservation across mammalian species studied so far, whereas expression of AT2 receptors is more variable, and is more restricted in the human CNS than in many other mammals. These differences between the subtype distributions in humans and other animals indicate the need for care when extrapolating the results of animal studies involving the brain angiotensin system.en
dc.language.isoenen
dc.subject.otherAgeden
dc.subject.otherAged, 80 and overen
dc.subject.otherAngiotensin II.antagonists & inhibitors.metabolismen
dc.subject.otherAngiotensin Receptor Antagonistsen
dc.subject.otherAutoradiographyen
dc.subject.otherBiphenyl Compounds.pharmacologyen
dc.subject.otherBrain.drug effects.metabolismen
dc.subject.otherCentral Nervous System.drug effects.metabolismen
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherImidazoles.pharmacologyen
dc.subject.otherLosartanen
dc.subject.otherMaleen
dc.subject.otherPyridines.pharmacologyen
dc.subject.otherRadioligand Assayen
dc.subject.otherReceptors, Angiotensin.agonists.metabolismen
dc.subject.otherSpinal Cord.drug effects.metabolismen
dc.subject.otherTetrazoles.pharmacologyen
dc.titleAngiotensin II receptor subtypes in the human central nervous system.en
dc.typeJournal Articleen
dc.identifier.journaltitleBrain Researchen
dc.identifier.affiliationDepartment of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Australiaen
dc.description.pages231-40en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/7796134en
dc.type.austinJournal Articleen
local.name.researcherMurone, Carmel
item.languageiso639-1en-
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
crisitem.author.deptOlivia Newton-John Cancer Research Institute-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Oct 4, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.